Trial Profile
Intraocular Pharmacokinetics of Aflibercept and Vascular Endothelial Growth Factor-A
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Pharmacokinetics
- 12 Nov 2015 New trial record